Found: 119
Select item for more details and to access through your institution.
Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03210-8
- By:
- Publication type:
- Article
Distribution of Group III mGluRs in Rat Basal Ganglia with Subtype-Specific Antibodies.
- Published in:
- Annals of the New York Academy of Sciences, 1999, v. 868, n. 1, p. 531, doi. 10.1111/j.1749-6632.1999.tb11322.x
- By:
- Publication type:
- Article
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Genetic influences on cognition in progressive supranuclear palsy.
- Published in:
- Movement Disorders, 2017, v. 32, n. 12, p. 1764, doi. 10.1002/mds.27196
- By:
- Publication type:
- Article
What would Dr. James parkinson think today? Mutations in beta-glucocerebrosidase and risk of Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- editorial
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cholinergic regulation of striatal dopamine release: New light in dark basements.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
SNPing SCNA regulatory elements gives a CRISPR view of genetic susceptibility in Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis.
- Published in:
- 2016
- By:
- Publication type:
- editorial
Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Invisible Killers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel.
- Published in:
- Movement Disorders, 2015, v. 30, n. 10, p. 1435, doi. 10.1002/mds.26316
- By:
- Publication type:
- Article
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results.
- Published in:
- Movement Disorders, 2015, v. 30, n. 4, p. 500, doi. 10.1002/mds.26123
- By:
- Publication type:
- Article
Scientific perspectives.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegeneration.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegeneration.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Metabolomics and the search for biomarkers in Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 12, p. 1620, doi. 10.1002/mds.25644
- By:
- Publication type:
- Article
Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit.
- Published in:
- Movement Disorders, 2013, v. 28, n. 12, p. 1675, doi. 10.1002/mds.25625
- By:
- Publication type:
- Article
Parkinson's disease, primates, and gene therapy: vive la différence?
- Published in:
- 2011
- By:
- Publication type:
- editorial
Parkinson's disease, primates, and gene therapy: Vive la différence?
- Published in:
- Movement Disorders, 2011, v. 26, n. 1, p. 2, doi. 10.1002/mds.23544
- By:
- Publication type:
- Article
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.
- Published in:
- NPJ Parkinson's Disease, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41531-020-0112-6
- By:
- Publication type:
- Article
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics.
- Published in:
- NPJ Parkinson's Disease, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0040-2
- By:
- Publication type:
- Article
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0013-5
- By:
- Publication type:
- Article
Organization of atriopeptin-like immunoreactive neurons in the central nervous system of the rat.
- Published in:
- Journal of Comparative Neurology, 1986, v. 253, n. 3, p. 315, doi. 10.1002/cne.902530304
- By:
- Publication type:
- Article
Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia.
- Published in:
- Frontiers in Systems Neuroscience, 2017, p. 1, doi. 10.3389/fnsys.2017.00043
- By:
- Publication type:
- Article
MHCII Is Required for α-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration.
- Published in:
- Journal of Neuroscience, 2013, v. 33, n. 23, p. 9592, doi. 10.1523/JNEUROSCI.5610-12.2013
- By:
- Publication type:
- Article
Cholinergic Dysfunction Alters Synaptic Integration between Thalamostriatal and Corticostriatal Inputs in DYT1 Dystonia.
- Published in:
- Journal of Neuroscience, 2012, v. 32, n. 35, p. 11991, doi. 10.1523/JNEUROSCI.0041-12.2012
- By:
- Publication type:
- Article
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses.
- Published in:
- Journal of Neuroscience, 2012, v. 32, n. 5, p. 1602, doi. 10.1523/JNEUROSCI.5601-11.2012
- By:
- Publication type:
- Article
Removing the blinkers: moving beyond striatal dopamine in Parkinson's disease.
- Published in:
- Journal of Neurochemistry, 2013, v. 125, n. 5, p. 639, doi. 10.1111/jnc.12167
- By:
- Publication type:
- Article
A neuroprotective role for angiogenin in models of Parkinson's disease.
- Published in:
- Journal of Neurochemistry, 2011, v. 116, n. 3, p. 334, doi. 10.1111/j.1471-4159.2010.07112.x
- By:
- Publication type:
- Article
Striatal histone modifications in models of levodopa-induced dyskinesia.
- Published in:
- Journal of Neurochemistry, 2008, v. 106, n. 1, p. 486, doi. 10.1111/j.1471-4159.2008.05417.x
- By:
- Publication type:
- Article
Dopamine release is impaired in a mouse model of DYT1 dystonia.
- Published in:
- Journal of Neurochemistry, 2007, v. 102, n. 3, p. 783, doi. 10.1111/j.1471-4159.2007.04590.x
- By:
- Publication type:
- Article
Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.
- Published in:
- Journal of Neurochemistry, 2007, v. 100, n. 6, p. 1449, doi. 10.1111/j.1471-4159.2006.04310.x
- By:
- Publication type:
- Article
The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia.
- Published in:
- Journal of Neuroinflammation, 2012, v. 9, n. 1, p. 259, doi. 10.1186/1742-2094-9-259
- By:
- Publication type:
- Article
Racial Differences in Parkinson’s Disease Medication Use in the Reasons for Geographic and Racial Differences in Stroke Cohort: A Cross-Sectional Study.
- Published in:
- Neuroepidemiology, 2009, v. 33, n. 4, p. 329, doi. 10.1159/000254568
- By:
- Publication type:
- Article
LRRK2 secretion in exosomes is regulated by 14-3-3.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 24, p. 4988, doi. 10.1093/hmg/ddt346
- By:
- Publication type:
- Article
Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington’s disease: neuronal selectivity and potential neuroprotective role of HAP1.
- Published in:
- Human Molecular Genetics, 2005, v. 14, n. 2, p. 179, doi. 10.1093/hmg/ddi014
- By:
- Publication type:
- Article
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation.
- Published in:
- Molecular Neurodegeneration, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13024-024-00738-4
- By:
- Publication type:
- Article
CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Glucocerebrosidase, Parkinson disease, and the "senses and intellect".
- Published in:
- 2016
- By:
- Publication type:
- journal article
T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease.
- Published in:
- Acta Neuropathologica, 2020, v. 139, n. 5, p. 855, doi. 10.1007/s00401-020-02126-w
- By:
- Publication type:
- Article
No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer’s disease brain.
- Published in:
- Acta Neuropathologica, 2006, v. 112, n. 4, p. 439, doi. 10.1007/s00401-006-0095-3
- By:
- Publication type:
- Article
The pathophysiological basis of dystonias.
- Published in:
- 2008
- By:
- Publication type:
- journal article
DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2021, v. 8, n. 7, p. 1061, doi. 10.1002/mdc3.13239
- By:
- Publication type:
- Article
Brain Alchemy: Transforming Astrocytes into Neurons for Neurodegenerative Disease.
- Published in:
- Movement Disorders Clinical Practice, 2020, v. 7, n. 8, p. 902, doi. 10.1002/mdc3.13090
- By:
- Publication type:
- Article
Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats.
- Published in:
- Movement Disorders Clinical Practice, 2019, v. 6, n. 4, p. 336, doi. 10.1002/mdc3.12738
- By:
- Publication type:
- Article
Implementing Levodopa‐Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners.
- Published in:
- Movement Disorders Clinical Practice, 2018, v. 5, n. 4, p. 383, doi. 10.1002/mdc3.12630
- By:
- Publication type:
- Article
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2017, v. 4, n. 6, p. 829, doi. 10.1002/mdc3.12526
- By:
- Publication type:
- Article